Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial - Chagas, Marcos Hortes N; Zuardi, Antonio W; Tumas, Vitor; Pena-Pereira, Márcio Alexandre; Sobreira, Emmanuelle T; Bergamaschi, Mateus M; dos Santos, Antonio Carlos; Teixeira, Antonio Lucio; Hallak, Jaime E C; Crippa, José Alexandre S (Journal of psychopharmacology (Oxford), 2014)
Keywords: Aged; Aged, 80 and over; Aspartic Acid - analogs & derivatives; Aspartic Acid - metabolism; Brain-Derived Neurotrophic Factor - blood; Cannabidiol - therapeutic use; Creatine - metabolism; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuroprotective Agents - blood; Neuroprotective Agents - therapeutic use; Parkinson Disease - drug therapy; Proton Magnetic Resonance Spectroscopy; Putamen - metabolism; Quality of Life; Severity of Illness Index; Treatment Outcome; cannabidiol; cannabis; treatment; Parkinson’s disease